Results

Total Results: 1,558 records

Showing results for "participant".

381. Disposition of Comments_Systematic Review_Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-disposition-comments.pdf
     November 22, 2024 - Disposition of Comments_Systematic Review_Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review Systematic Review Disposition of Comments Report Title: Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review Draft report available for public comment from …

382. Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in Adults Disposition of Comments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation_disposition-comments.pdf
     October 07, 2012 - Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in Adults Disposition of Comments Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1141 Published Online: April 2012 Comparative Effectiveness Resea…

383. Executive Summary_Comparative Effectiveness Review No. 261_Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-261-postpartum-care-executive-summary.pdf
     June 01, 2023 - Executive Summary_Comparative Effectiveness Review No. 261_Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis Comparative Effectiveness Review Number 261 Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis Executive Summary Main Points …

384. Cer-238-Cervical-Ripening-Appendix-E-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
     January 01, 2009 - contractions were less than 3 in 10 minutes, she had no painful contractions, and FHT were reassuring, participant … dose of gel placed -Fetal heart rate also monitored continuously for another 2 hour minimum if the participant

385. Appendix Table B-1. RCTs of Masks (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
     April 09, 2020 - by PCR within 7 days of symptom onset; influena from a randomly obtained swab from an asymptomatic participant

386. Masks-Surveillance-2-Appendix-Table-A-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
     April 09, 2020 - by PCR within 7 days of symptom onset; influena from a randomly obtained swab from an asymptomatic participant

387. Masks-Appendix-Table-B-1-Version-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
     April 09, 2020 - by PCR within 7 days of symptom onset; influena from a randomly obtained swab from an asymptomatic participant

388. Masks-Appendix-Table-B-1-Surveillance-Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
     April 09, 2020 - by PCR within 7 days of symptom onset; influena from a randomly obtained swab from an asymptomatic participant

389. Masks for Prevention of COVID-19 in Community and Healthcare Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-1.pdf
     December 01, 2021 - Two RCTs16,24 were randomized by individual participant; the remaining trials were randomized by clusters

390. Ch 2-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
     January 01, 2011 - 21 Abstract The choice of study design often has profound consequences for the causal interpretation of study results. The objective of this chapter is to provide an overview of various study design options for nonexperimental comparative effectiveness research (CER), with their relative advantages and limitations,…

391. Hunt_Panel_3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/hunt_panel_3.pdf
     January 01, 2010 - Hunt_Panel_3 Slide  1: Addressing Health Disparities: Why Use Web 2.0? Yvonne M. Hunt, Ph.D., M.P.H. Cancer Prevention Fellow National Cancer Institute, Bethesda, MD Slide  2: Social Media  “Disparities” • Among those who use social media, use is hi…

392. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - hospital or clinic record number; or allocation by judgement of the clinician, preference of the participant

393. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - The AHRQ Task Order Officer was a participant in all group teleconferences and was included on all electronic

394. Ced -Appendix-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
     May 29, 2025 - Summary_Out of Scope Comments There were many comments that were outside of the scope of this project in that they addressed the CED process rather including when and how it should be implemented. Multiple comments proposed that AHRQ should undertake a similar exercise to this one, with the goal of revising the CED p…

395. Disposition of Comments for CER 195 Management of Uterine Fibroids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
     December 14, 2017 - For simple descriptions very few studies identified outcomes by participant or fibroid characteristics

396. Rapid Evidence Product: Masks for Prevention of COVID-19 in Community and Healthcare Settings Version 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-2.pdf
     December 01, 2021 - Two RCTs16,24 were randomized by individual participant; the remaining trials were randomized by clusters

397. Fecal-Incontinence Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
     November 30, 2014 - and control characteristics (intervention delivery, timing, frequency, duration), followup duration, participant … Items included from the RTI Item Bank address participant selection, group membership, efforts to address

398. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.a…

399. FRN 39 - Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
     February 01, 2013 - or experiment$ or analys$ or analyz$).mp. (8946248) 37 ((control$ or prospectiv$ or volunteer$ or participant

400. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - DEMENTIA INCLUDING ALZHEIMER'S #04 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 04: Dementia (Including Alzheimer’s Disease) Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockvi…